SlideShare une entreprise Scribd logo
1  sur  27
DR.PRAVEEN NAGULA
Single blind randomized study

David S Wald et al,
NEJM 2013;369:1115-23


In acute ST segment elevation myocardial infarction(STEMI),the
use of percutaneous coronary intervention(PCI) to treat the artery
responsible for the infarct(infarct or culprit artery) improves
prognosis.
THE PREVENTIVE PCI







From 2008 through 2013
465 patients at five coronary care centers in UK.
Consecutive patients of any age with acute STEMI and
multivessel coronary disease detected at the time of emergency
PCI.
Trial was limited to patients with STEMI.


Patients were considered for eligibility after undergoing PCI in
the infarct artery, in catheterization laboratory.



Deemed to be eligible if the infarct artery had been treated
successfully and there was stenosis of ≥50% in one or more
coronary arteries other than the infarct artery and treatable by
PCI.



The treating cardiologist had to consider that both infarct
artery- only PCI and preventive PCI would be acceptable
treatment options.
Patients in
 Cardiogenic shock
 Unable to provide consent
 Previous CABG
 Left main ,ostial LAD,LCX stenosis of ≥ 50%(CABG
indications)
 Non infarct stenosis being a chronic total occlusion (PCI is C/I).
Primary outcome:
 Composite of death from cardiac causes,non fatal myocardial
infarction,or refractory angina.
 Each component was assessed individually.

Secondary outcomes:
 Death from noncardiac causes
 Repeat revascularization procedures (PCI or CABG).


Independent cardiologist and cardiac surgeon who were not
notified about study group assignments examined specified
primary and secondary outcomes.


For a power of at least 80% to detect a reduction in risk of 30% in
the preventive PCI group,as compared with other,at a level of 5%
significance, assuming a 20% annual rate of the primary outcome
in the latter group – 600 patients to be enrolled.




Survival outcomes by log rank statistic.
Stopping criteria included a clear answer to the trial question from
the emerging literature or from the results of the trial,(P<0.001).



All were included in analysis on an intention to treat basis.


Recruitment stopped early after noting a significant between
group difference (P<0.001) in the incidence of the primary
outcome favoring the preventive PCI.



465 patients were enrolled.



234 –preventive PCI,231 to non preventive PCI.
Mean follow up was 23 months.






67% patients were followed for atleast 1yr.
46% pts -2 yrs.
10 pts in preventive PCI ,8 in the other group lost to follow up.
Preventive PCI

no Preventive PCI

Primary outcome

21 pts

53 pts

Event rates

9/100

23/100

Absolute risk reduction

14%

STEMI

2

9

NSTEMI

5

11

Stent thrombosis

2

3

Ischemia testing

1/6

1/3

asymptomatic

8

44

symptomatic

31

37


Risk reduction in the preventive PCI group was evident within
the 6 months after the procedure and was maintained thereafter.



The rate of death from non cardiac causes did not differ
significantly between the two study groups.(hazard
ratio,1.10;95%CI,0.38 to 3.18;P=0.86)



The results were not materially affected by the five
prespecified covariates – age sex, of diabetes,infarct
location,and the number of coronary arteries with stenosis.


Procedure time,fluoroscopy dose,and contrast volume were
increased in the preventive PCI group.



Rates of complications(procedure related stroke,bleeding
requiring transfusion,surgery,CIN requiring dialysis)were
similar in both groups.



Median length of stay in the hospital was 2 days with 95%
patients being discharged within 1 week.
In one study
 69 patients were randomly assigned (3:1ratio) to preventive
PCI in patients with acute STEMI undergoing PCI in the
infarct artery.


At 1 year, in the preventive PCI group,there were
nonsignificant reductions in the rates of repeat
revascularization (17% and 35%)and cardiac death or
myocardial infarction (4%and 6%) respectively.

Di Mario et al ,HELP AMI study.
Int J Cardiovasc Intervent 2004;6:128-33
In the other trial,
 214 patients were randomly assigned to one of three groups;
 No preventive PCI(84 pts),immediate preventive
PCI(65pts),and staged preventive PCI performed during a
second procedure about 40 days later(65 pts)
 At 2.5 yrs the rate of repeat revascularization was less frequent
in the immediate and staged preventive PCI groups combined,as
compared with the group receiving no preventive PCI(11% and
33% respectively).
 Nonsignificant decrease in the rate of cardiac death (5 and 12 %
respectively).

Politi et al , Heart 2010;96:662-7.
Studies

MVA

IRA

MORTALITY/
events

P value

Others

Kong et al

632

1350

0.8vs2.3%

P-0.018

OR-0.27

Khattab et al

28

45

24 vs28%

P-0.73

Qarawani et al

95

25

16.7vs52%
P-0.0001
Renal dysf(8.4%
vs 4%)

Chen et al

239

1145

equal

P-0.78

Varani et al

243

156

2.3%vs 6.3%

P-.023



Politi L et al, HEART 2010;96:662-7. Kong JA et al ,Coronary Artery Dis 2006;17:71-5.



Khattab A et al , Clin Rese Cardiol 2008;97:32-8. Qarawani D et al ,Int J Cardiol 2008;123:288-92.



Chen LY et al ,Am J Cardiol 2005;95:349-54. Varani et al ,Catheter Cardiovasc Interven 2008;72:927-33.
Study

Pvalue

reinfarction

2.8%

13.8%

0.001

25%

15%

0.007

Mortality in pts with
Card.shock

27.8%

36.5%

0.01

overall

Cavender et al

MultiPCI

revascularization

Roberto et al

IRA

7.9%

5.1%

0.01

Corpus et al, Am Heart J 2004;148:493-500 Roe et al, Am J Cardiol 2001;88:170-3,A6.
Cavender MA et al, Am J Caridol 2009;104:507-13. Hannan EL et al, JACC Cardiovasc Interven 2010;3:22-31
Toma et al ,APEX-AMI trial, Eur Heart J 2010;31;1701-7.
Lack of statistical power
Reliance on repeat revascularization
Current guidelines recommend only infarct artery only PCI in
patients with multivessel disease,owing to a lack of evidence
with respect to preventive PCI
1.Immedicate versus staged PCI.
2.Are the benefits of preventive PCI applicable to NSTEMI.
3.Do the benefits extend to the stenoses less than 50%.
4.Level of stenoses at which the risks of PCI outweigh
benefits.
5.Would FFR offer an advantage over angiographic visual
assessment in guiding preventive PCI


In patients undergoing emergency infarct artery PCI for
acute STEMI, preventive PCI of stenoses in noninfarct

arteries reduced the risk of subsequent adverse
cardiovascular events,as compared with PCI limited to the
infarct artery.
Prami trial

Contenu connexe

Tendances

Patent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.pptPatent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.pptAliaa Shaban
 
Cardiology trials overview
Cardiology trials overviewCardiology trials overview
Cardiology trials overviewBasil Tumaini
 
Retrograde approach Step by Step
Retrograde approach Step by StepRetrograde approach Step by Step
Retrograde approach Step by StepEuro CTO Club
 
Heart failure update
Heart failure updateHeart failure update
Heart failure updateSushant Yadav
 
Cardio oncology guidelines ESC 2022
Cardio oncology guidelines ESC 2022  Cardio oncology guidelines ESC 2022
Cardio oncology guidelines ESC 2022 AhmedElBorae1
 
MINOCA , Myocardial Infarction with Non-Obstructive Coronary Arteries
MINOCA ,  Myocardial Infarction with Non-Obstructive Coronary ArteriesMINOCA ,  Myocardial Infarction with Non-Obstructive Coronary Arteries
MINOCA , Myocardial Infarction with Non-Obstructive Coronary Arteriesmagdy elmasry
 
Bypass graft intervention2
Bypass graft intervention2Bypass graft intervention2
Bypass graft intervention2Dr Virbhan Balai
 
LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”Arindam Pande
 
Coronary revascularization in diabetes mellitus and multivessel cad
Coronary revascularization in diabetes mellitus and multivessel cadCoronary revascularization in diabetes mellitus and multivessel cad
Coronary revascularization in diabetes mellitus and multivessel cadSatyam Rajvanshi
 
Emphasis hf-101115080855-phpapp02
Emphasis hf-101115080855-phpapp02Emphasis hf-101115080855-phpapp02
Emphasis hf-101115080855-phpapp02Trimed Media Group
 
Coronary Calcium Modification
Coronary Calcium ModificationCoronary Calcium Modification
Coronary Calcium ModificationNAJEEB ULLAH SOFI
 
Coronary artery dissection and perforation
Coronary artery dissection and perforationCoronary artery dissection and perforation
Coronary artery dissection and perforationFuad Farooq
 
Cardio renal-syndrome
Cardio renal-syndromeCardio renal-syndrome
Cardio renal-syndromeraj shekar
 

Tendances (20)

Svg pci
Svg pciSvg pci
Svg pci
 
Coronary stent thrombosis
Coronary stent thrombosisCoronary stent thrombosis
Coronary stent thrombosis
 
COMPLETE Trial
COMPLETE TrialCOMPLETE Trial
COMPLETE Trial
 
Pharmacoinvasive approach for stemi
Pharmacoinvasive approach for stemiPharmacoinvasive approach for stemi
Pharmacoinvasive approach for stemi
 
Patent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.pptPatent Foramen Ovale,practical plan of handling.ppt
Patent Foramen Ovale,practical plan of handling.ppt
 
CABG VS PCI
CABG VS PCI CABG VS PCI
CABG VS PCI
 
Cardiology trials overview
Cardiology trials overviewCardiology trials overview
Cardiology trials overview
 
Retrograde approach Step by Step
Retrograde approach Step by StepRetrograde approach Step by Step
Retrograde approach Step by Step
 
Heart failure update
Heart failure updateHeart failure update
Heart failure update
 
Cardio oncology guidelines ESC 2022
Cardio oncology guidelines ESC 2022  Cardio oncology guidelines ESC 2022
Cardio oncology guidelines ESC 2022
 
MINOCA , Myocardial Infarction with Non-Obstructive Coronary Arteries
MINOCA ,  Myocardial Infarction with Non-Obstructive Coronary ArteriesMINOCA ,  Myocardial Infarction with Non-Obstructive Coronary Arteries
MINOCA , Myocardial Infarction with Non-Obstructive Coronary Arteries
 
Bypass graft intervention2
Bypass graft intervention2Bypass graft intervention2
Bypass graft intervention2
 
LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”
 
Coronary revascularization in diabetes mellitus and multivessel cad
Coronary revascularization in diabetes mellitus and multivessel cadCoronary revascularization in diabetes mellitus and multivessel cad
Coronary revascularization in diabetes mellitus and multivessel cad
 
Emphasis hf-101115080855-phpapp02
Emphasis hf-101115080855-phpapp02Emphasis hf-101115080855-phpapp02
Emphasis hf-101115080855-phpapp02
 
Aortic Aneurysm.pdf
Aortic Aneurysm.pdfAortic Aneurysm.pdf
Aortic Aneurysm.pdf
 
ISAR REACT Study
ISAR REACT StudyISAR REACT Study
ISAR REACT Study
 
Coronary Calcium Modification
Coronary Calcium ModificationCoronary Calcium Modification
Coronary Calcium Modification
 
Coronary artery dissection and perforation
Coronary artery dissection and perforationCoronary artery dissection and perforation
Coronary artery dissection and perforation
 
Cardio renal-syndrome
Cardio renal-syndromeCardio renal-syndrome
Cardio renal-syndrome
 

Similaire à Prami trial

DANISH trial (Cardiology)
 DANISH trial (Cardiology) DANISH trial (Cardiology)
DANISH trial (Cardiology)PRAVEEN GUPTA
 
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...Premier Publishers
 
Three New Trials in Stroke
Three New Trials in StrokeThree New Trials in Stroke
Three New Trials in StrokeDr Pradip Mate
 
Appropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationAppropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationLalit Kapoor
 
Appropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationAppropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationLalit Kapoor
 
Debate of opening non infarct related arteries
Debate of opening non infarct related arteriesDebate of opening non infarct related arteries
Debate of opening non infarct related arteriesSwapnil Garde
 
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...Chaichuk Sergiy
 
PCI vs OMT vs CABG in Stable CAD
PCI vs OMT vs CABG in Stable CADPCI vs OMT vs CABG in Stable CAD
PCI vs OMT vs CABG in Stable CADVivek Rana
 
08:25 Di Mario - Recent Pubblications and Research
08:25 Di Mario - Recent Pubblications and Research08:25 Di Mario - Recent Pubblications and Research
08:25 Di Mario - Recent Pubblications and ResearchEuro CTO Club
 
Primary PCI: State of the art. Petr Widimsky
Primary PCI: State of the art. Petr WidimskyPrimary PCI: State of the art. Petr Widimsky
Primary PCI: State of the art. Petr WidimskyChaichuk Sergiy
 
Important Clinical Trials In Cardiology - An Overview 2016-17
Important Clinical Trials In Cardiology - An Overview 2016-17Important Clinical Trials In Cardiology - An Overview 2016-17
Important Clinical Trials In Cardiology - An Overview 2016-17Amit Verma
 

Similaire à Prami trial (20)

DANISH trial (Cardiology)
 DANISH trial (Cardiology) DANISH trial (Cardiology)
DANISH trial (Cardiology)
 
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
 
Scientific news march 2015 samir rafla
Scientific news march 2015 samir raflaScientific news march 2015 samir rafla
Scientific news march 2015 samir rafla
 
Three New Trials in Stroke
Three New Trials in StrokeThree New Trials in Stroke
Three New Trials in Stroke
 
Statins: Friend or foe?
Statins: Friend or foe?Statins: Friend or foe?
Statins: Friend or foe?
 
Factors determining outcomes in grown up patients operated
Factors determining outcomes in grown up patients operatedFactors determining outcomes in grown up patients operated
Factors determining outcomes in grown up patients operated
 
Appropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationAppropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary Revascularization
 
Appropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary RevascularizationAppropriteness Criteria for Coronary Revascularization
Appropriteness Criteria for Coronary Revascularization
 
Debate of opening non infarct related arteries
Debate of opening non infarct related arteriesDebate of opening non infarct related arteries
Debate of opening non infarct related arteries
 
Thromboectomy trial
Thromboectomy trialThromboectomy trial
Thromboectomy trial
 
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
 
PCI vs OMT vs CABG in Stable CAD
PCI vs OMT vs CABG in Stable CADPCI vs OMT vs CABG in Stable CAD
PCI vs OMT vs CABG in Stable CAD
 
Estudio ODYSSEY OUTCOMES: los expertos opinan. Dra. Badimon
Estudio ODYSSEY OUTCOMES: los expertos opinan. Dra. BadimonEstudio ODYSSEY OUTCOMES: los expertos opinan. Dra. Badimon
Estudio ODYSSEY OUTCOMES: los expertos opinan. Dra. Badimon
 
2008.02.12 Massie Hyperlipidemia
2008.02.12    Massie   Hyperlipidemia2008.02.12    Massie   Hyperlipidemia
2008.02.12 Massie Hyperlipidemia
 
Jose miguel vegas valle sec sept2015
Jose miguel vegas valle sec sept2015Jose miguel vegas valle sec sept2015
Jose miguel vegas valle sec sept2015
 
Mdct2
Mdct2Mdct2
Mdct2
 
08:25 Di Mario - Recent Pubblications and Research
08:25 Di Mario - Recent Pubblications and Research08:25 Di Mario - Recent Pubblications and Research
08:25 Di Mario - Recent Pubblications and Research
 
CONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTSCONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTS
 
Primary PCI: State of the art. Petr Widimsky
Primary PCI: State of the art. Petr WidimskyPrimary PCI: State of the art. Petr Widimsky
Primary PCI: State of the art. Petr Widimsky
 
Important Clinical Trials In Cardiology - An Overview 2016-17
Important Clinical Trials In Cardiology - An Overview 2016-17Important Clinical Trials In Cardiology - An Overview 2016-17
Important Clinical Trials In Cardiology - An Overview 2016-17
 

Plus de Praveen Nagula

historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptxPraveen Nagula
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxPraveen Nagula
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptxPraveen Nagula
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONPraveen Nagula
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxPraveen Nagula
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxPraveen Nagula
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxPraveen Nagula
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not samePraveen Nagula
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIPraveen Nagula
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL Praveen Nagula
 

Plus de Praveen Nagula (20)

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptx
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptx
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptx
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptx
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptx
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSION
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptx
 
8.FEMI.pptx
8.FEMI.pptx8.FEMI.pptx
8.FEMI.pptx
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptx
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptx
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptx
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptx
 
QUIZ IV
QUIZ IVQUIZ IV
QUIZ IV
 
QUIZ .pptx
QUIZ .pptxQUIZ .pptx
QUIZ .pptx
 
QUIZ
QUIZ QUIZ
QUIZ
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART II
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 

Dernier

ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17Celine George
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseCeline George
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleCeline George
 
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
Unraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptxUnraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptx
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptxDhatriParmar
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWQuiz Club NITW
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operationalssuser3e220a
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxkarenfajardo43
 
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Association for Project Management
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvRicaMaeCastro1
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSMae Pangan
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQuiz Club NITW
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...Nguyen Thanh Tu Collection
 

Dernier (20)

ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 Database
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP Module
 
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
Unraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptxUnraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptx
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITW
 
Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operational
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
 
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHS
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
 

Prami trial

  • 2. Single blind randomized study David S Wald et al, NEJM 2013;369:1115-23
  • 3.  In acute ST segment elevation myocardial infarction(STEMI),the use of percutaneous coronary intervention(PCI) to treat the artery responsible for the infarct(infarct or culprit artery) improves prognosis.
  • 5.     From 2008 through 2013 465 patients at five coronary care centers in UK. Consecutive patients of any age with acute STEMI and multivessel coronary disease detected at the time of emergency PCI. Trial was limited to patients with STEMI.
  • 6.
  • 7.  Patients were considered for eligibility after undergoing PCI in the infarct artery, in catheterization laboratory.  Deemed to be eligible if the infarct artery had been treated successfully and there was stenosis of ≥50% in one or more coronary arteries other than the infarct artery and treatable by PCI.  The treating cardiologist had to consider that both infarct artery- only PCI and preventive PCI would be acceptable treatment options.
  • 8. Patients in  Cardiogenic shock  Unable to provide consent  Previous CABG  Left main ,ostial LAD,LCX stenosis of ≥ 50%(CABG indications)  Non infarct stenosis being a chronic total occlusion (PCI is C/I).
  • 9. Primary outcome:  Composite of death from cardiac causes,non fatal myocardial infarction,or refractory angina.  Each component was assessed individually. Secondary outcomes:  Death from noncardiac causes  Repeat revascularization procedures (PCI or CABG).  Independent cardiologist and cardiac surgeon who were not notified about study group assignments examined specified primary and secondary outcomes.
  • 10.  For a power of at least 80% to detect a reduction in risk of 30% in the preventive PCI group,as compared with other,at a level of 5% significance, assuming a 20% annual rate of the primary outcome in the latter group – 600 patients to be enrolled.   Survival outcomes by log rank statistic. Stopping criteria included a clear answer to the trial question from the emerging literature or from the results of the trial,(P<0.001).  All were included in analysis on an intention to treat basis.
  • 11.  Recruitment stopped early after noting a significant between group difference (P<0.001) in the incidence of the primary outcome favoring the preventive PCI.  465 patients were enrolled.  234 –preventive PCI,231 to non preventive PCI. Mean follow up was 23 months.     67% patients were followed for atleast 1yr. 46% pts -2 yrs. 10 pts in preventive PCI ,8 in the other group lost to follow up.
  • 12.
  • 13.
  • 14. Preventive PCI no Preventive PCI Primary outcome 21 pts 53 pts Event rates 9/100 23/100 Absolute risk reduction 14% STEMI 2 9 NSTEMI 5 11 Stent thrombosis 2 3 Ischemia testing 1/6 1/3 asymptomatic 8 44 symptomatic 31 37
  • 15.  Risk reduction in the preventive PCI group was evident within the 6 months after the procedure and was maintained thereafter.  The rate of death from non cardiac causes did not differ significantly between the two study groups.(hazard ratio,1.10;95%CI,0.38 to 3.18;P=0.86)  The results were not materially affected by the five prespecified covariates – age sex, of diabetes,infarct location,and the number of coronary arteries with stenosis.
  • 16.  Procedure time,fluoroscopy dose,and contrast volume were increased in the preventive PCI group.  Rates of complications(procedure related stroke,bleeding requiring transfusion,surgery,CIN requiring dialysis)were similar in both groups.  Median length of stay in the hospital was 2 days with 95% patients being discharged within 1 week.
  • 17.
  • 18.
  • 19. In one study  69 patients were randomly assigned (3:1ratio) to preventive PCI in patients with acute STEMI undergoing PCI in the infarct artery.  At 1 year, in the preventive PCI group,there were nonsignificant reductions in the rates of repeat revascularization (17% and 35%)and cardiac death or myocardial infarction (4%and 6%) respectively. Di Mario et al ,HELP AMI study. Int J Cardiovasc Intervent 2004;6:128-33
  • 20. In the other trial,  214 patients were randomly assigned to one of three groups;  No preventive PCI(84 pts),immediate preventive PCI(65pts),and staged preventive PCI performed during a second procedure about 40 days later(65 pts)  At 2.5 yrs the rate of repeat revascularization was less frequent in the immediate and staged preventive PCI groups combined,as compared with the group receiving no preventive PCI(11% and 33% respectively).  Nonsignificant decrease in the rate of cardiac death (5 and 12 % respectively). Politi et al , Heart 2010;96:662-7.
  • 21. Studies MVA IRA MORTALITY/ events P value Others Kong et al 632 1350 0.8vs2.3% P-0.018 OR-0.27 Khattab et al 28 45 24 vs28% P-0.73 Qarawani et al 95 25 16.7vs52% P-0.0001 Renal dysf(8.4% vs 4%) Chen et al 239 1145 equal P-0.78 Varani et al 243 156 2.3%vs 6.3% P-.023  Politi L et al, HEART 2010;96:662-7. Kong JA et al ,Coronary Artery Dis 2006;17:71-5.  Khattab A et al , Clin Rese Cardiol 2008;97:32-8. Qarawani D et al ,Int J Cardiol 2008;123:288-92.  Chen LY et al ,Am J Cardiol 2005;95:349-54. Varani et al ,Catheter Cardiovasc Interven 2008;72:927-33.
  • 22. Study Pvalue reinfarction 2.8% 13.8% 0.001 25% 15% 0.007 Mortality in pts with Card.shock 27.8% 36.5% 0.01 overall Cavender et al MultiPCI revascularization Roberto et al IRA 7.9% 5.1% 0.01 Corpus et al, Am Heart J 2004;148:493-500 Roe et al, Am J Cardiol 2001;88:170-3,A6. Cavender MA et al, Am J Caridol 2009;104:507-13. Hannan EL et al, JACC Cardiovasc Interven 2010;3:22-31 Toma et al ,APEX-AMI trial, Eur Heart J 2010;31;1701-7.
  • 23. Lack of statistical power Reliance on repeat revascularization
  • 24. Current guidelines recommend only infarct artery only PCI in patients with multivessel disease,owing to a lack of evidence with respect to preventive PCI
  • 25. 1.Immedicate versus staged PCI. 2.Are the benefits of preventive PCI applicable to NSTEMI. 3.Do the benefits extend to the stenoses less than 50%. 4.Level of stenoses at which the risks of PCI outweigh benefits. 5.Would FFR offer an advantage over angiographic visual assessment in guiding preventive PCI
  • 26.  In patients undergoing emergency infarct artery PCI for acute STEMI, preventive PCI of stenoses in noninfarct arteries reduced the risk of subsequent adverse cardiovascular events,as compared with PCI limited to the infarct artery.